IL51287A - 3-substituted-2-(thio)oxo-4-(4-halo-3-sulphamoylphenyl)-4-thiazolidinol derivatives,process for their preparation and saluretic and diuretic composotions containing them - Google Patents

3-substituted-2-(thio)oxo-4-(4-halo-3-sulphamoylphenyl)-4-thiazolidinol derivatives,process for their preparation and saluretic and diuretic composotions containing them

Info

Publication number
IL51287A
IL51287A IL51287A IL5128777A IL51287A IL 51287 A IL51287 A IL 51287A IL 51287 A IL51287 A IL 51287A IL 5128777 A IL5128777 A IL 5128777A IL 51287 A IL51287 A IL 51287A
Authority
IL
Israel
Prior art keywords
thiazolidinol
composotions
sulphamoylphenyl
saluretic
diuretic
Prior art date
Application number
IL51287A
Other languages
English (en)
Other versions
IL51287A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL51287A0 publication Critical patent/IL51287A0/xx
Publication of IL51287A publication Critical patent/IL51287A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL51287A 1976-01-20 1977-01-18 3-substituted-2-(thio)oxo-4-(4-halo-3-sulphamoylphenyl)-4-thiazolidinol derivatives,process for their preparation and saluretic and diuretic composotions containing them IL51287A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762601791 DE2601791A1 (de) 1976-01-20 1976-01-20 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
IL51287A0 IL51287A0 (en) 1977-03-31
IL51287A true IL51287A (en) 1980-05-30

Family

ID=5967727

Family Applications (1)

Application Number Title Priority Date Filing Date
IL51287A IL51287A (en) 1976-01-20 1977-01-18 3-substituted-2-(thio)oxo-4-(4-halo-3-sulphamoylphenyl)-4-thiazolidinol derivatives,process for their preparation and saluretic and diuretic composotions containing them

Country Status (20)

Country Link
US (1) US4129656A (xx)
JP (1) JPS5289669A (xx)
AT (1) AT356102B (xx)
AU (1) AU511547B2 (xx)
BE (1) BE850575A (xx)
CA (1) CA1078847A (xx)
DE (1) DE2601791A1 (xx)
DK (1) DK19777A (xx)
ES (4) ES455013A1 (xx)
FI (1) FI770142A (xx)
FR (1) FR2338937A1 (xx)
GB (1) GB1541974A (xx)
HU (1) HU175096B (xx)
IE (1) IE44213B1 (xx)
IL (1) IL51287A (xx)
IT (1) IT1077590B (xx)
LU (1) LU76597A1 (xx)
NL (1) NL7700381A (xx)
NO (1) NO770161L (xx)
SE (1) SE7700500L (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2737195A1 (de) * 1977-08-18 1979-03-01 Hoechst Ag Benzolsulfonamidderivate und verfahren zu ihrer herstellung
DE19731782A1 (de) * 1997-07-24 1999-01-28 Bayer Ag Verfahren zur Herstellung von Pyridylmethylisocyanaten
DE19908539A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US7271195B2 (en) * 2003-06-10 2007-09-18 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
WO2004110418A2 (en) * 2003-06-10 2004-12-23 Kalypsys, Inc. Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
CA2567835A1 (en) * 2004-06-10 2005-12-22 Kalypsys, Inc. Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
EP2202222A3 (en) * 2005-11-08 2010-09-15 Laboratorios Del Dr. Esteve, S.A. Indene derivatives, their preparation and use as medicaments
EP1884515A1 (en) * 2006-07-31 2008-02-06 Laboratorios del Dr. Esteve S.A. Substituted indanyl sulfonamide compounds, their preparation and use as medicaments
US20170202818A1 (en) 2014-07-18 2017-07-20 Ohio University Methods and compositions to modify gsk-3 activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671534A (en) * 1970-03-16 1972-06-20 Sandoz Ag 6,6-DI-LOWER ALKYL-2,3,5,6-TETRAHYDROIMIDAZO {8 2,1-b{9 {11 THIAZOLES
DE2546165A1 (de) * 1975-10-15 1977-04-28 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IE44213B1 (en) 1981-09-09
ES455013A1 (es) 1979-05-01
SE7700500L (sv) 1977-07-21
FR2338937B1 (xx) 1980-03-28
IL51287A0 (en) 1977-03-31
LU76597A1 (xx) 1977-07-27
ATA28277A (de) 1979-09-15
CA1078847A (en) 1980-06-03
IT1077590B (it) 1985-05-04
GB1541974A (en) 1979-03-14
ES475558A1 (es) 1979-05-16
ES475557A1 (es) 1979-05-01
AU511547B2 (en) 1980-08-21
AU2143377A (en) 1978-07-27
DE2601791A1 (de) 1977-07-21
DK19777A (da) 1977-07-21
ES475559A1 (es) 1979-05-01
NL7700381A (nl) 1977-07-22
BE850575A (fr) 1977-07-20
US4129656A (en) 1978-12-12
FI770142A (xx) 1977-07-21
NO770161L (no) 1977-07-21
FR2338937A1 (fr) 1977-08-19
HU175096B (hu) 1980-05-28
JPS5289669A (en) 1977-07-27
IE44213L (en) 1977-07-20
AT356102B (de) 1980-04-10

Similar Documents

Publication Publication Date Title
ZA763270B (en) New thieno(2,3-c)pyridine derivatives
ZA771303B (en) New 2,3-dihydro-amidazo(2,1-b)-thiazole derivatives and process for their preparation
IL51287A (en) 3-substituted-2-(thio)oxo-4-(4-halo-3-sulphamoylphenyl)-4-thiazolidinol derivatives,process for their preparation and saluretic and diuretic composotions containing them
GB1553113A (en) Cumylphenol derivatives
EG13910A (en) 1,3,4 substituted parazoline derivatives
AU521752B2 (en) Isochroman, isothiochroman, 2-benzoxepin and 2-benzthiepin derivatives
GB1520231A (en) Derivatives of 1,2-dithiole
IL56486A0 (en) Guanidine derivatives, their production and pharmaceuticalcompositions containing them
IL62824A0 (en) Taurine derivatives,their production and their use
AU508738B2 (en) 8-oxo-3-oxa-l-azabicycio [4,2,0] - cotane derivatives
PH15473A (en) N-benzylhaloacetamide derivatives,and their production and use
IL51877A0 (en) Omega-nor-aromatic-13,14-dehydro-prostaglandins and process for their preparation
IL52424A (en) 2,7-dihydroxy-5-isopropyliden-9-alkyl-2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxocin derivatives and process for their preparation
IL52099A (en) 5,6-dihydroprostacyclin derivatives and process for their preparation
AU504303B2 (en) Pesticidal iso-(thio)-urea derivatives
AU503926B2 (en) 1, 3-BENZODITHIOLE-2-ONE (and 2-THIONIC) DERIVATIVES
JPS532420A (en) Isothiourea derivatives
ZA79803B (en) New nitroso-urea derivatives and processes for producing them
ZA812259B (en) Sulfonamide derivatives, and their production and use
GB1533954A (en) Pyridoxine derivatives
ZA77307B (en) New thieno(3,2-c)pyridine derivatives
GB1544963A (en) Cyclopenta(b)thiophene derivatives
AU514596B2 (en) Vincamine derivatives
ZA77972B (en) Derivatives of dithiepino(1,4)(2,3-c)pyrrole
ZA773350B (en) New 1-substituted derivatives of 2,2-diphenylcyclopropane